GC
Girish Chandra Mainali
About Girish Chandra Mainali
Data last updated:
Girish Chandra Mainali has 2 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Alps Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Alps Pharmaceuticals Private Limited at ₹15.41 Cr (FY 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alps Pharmaceuticals Private Limited U24230GJ1980PTC047642 | Additional Director | 01 Jul 2024 | 1980 | ₹15.41 Cr (FY 2016) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Girish Chandra Mainali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Girish Chandra Mainali
Girish Chandra Mainali has 2 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Alps Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Alps Pharmaceuticals Private Limited at ₹15.41 Cr (FY 2016).
Girish Chandra Mainali is associated with 1 company as Additional Director, including Alps Pharmaceuticals Private Limited (₹15.41 Cr).
Girish Chandra Mainali has expertise in General Business.
Girish Chandra Mainali has 2 years in corporate governance.
By reported revenue, the largest current company of Girish Chandra Mainali is Alps Pharmaceuticals Private Limited, with revenue of ₹15.41 Cr (FY 2016).
Girish Chandra Mainali currently holds positions at 1 company: Alps Pharmaceuticals Private Limited (₹15.41 Cr).